cbdMD gets NYSE American plan acceptance for listing; equity at $3.1M, deadline Dec 2025

cbdMD, Inc.

NYSE American accepted cbdMD's plan to regain compliance; plan period through Dec 5, 2025.
Company had stockholders' equity of $3.1M as of Mar 31, 2024, below $4M requirement.
Correction: Original 8-K erroneously stated stockholders' deficit; correct figure is equity of $3.1M.
Company subject to quarterly review; failure to progress could lead to delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.